Comments

Verve Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Verve Therapeutics (VERV) operate in?

Verve Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

VERVNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q1 2025 Earnings were released on Wed May 14th, before the market open

Verve Therapeutics (VERV) Forecast

News Earnings Verve Therapeutics (VERV) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Verve Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:VERV | Benzinga

Explore Verve Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VERV.

Open	$4.37
Close	-
Volume / Avg.	862.90K / 3.02M
Day Range	$4.32 - $4.58
52 Wk Range	2.86 - 9.31
Market Cap	$404.71M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	24.6%
Days to Cover	5.33

Recent News

CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: Analyst

CRISPR reports data showing dose-dependent lipid reduction and strong safety, with plans to present full results in late 2025.

Vandana Singh

Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Netflix, Ericsson, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesday (CORRECTED)

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$4.37
Close	-
Volume / Avg.	862.90K / 3.02M
Day Range	$4.32 - $4.58
52 Wk Range	2.86 - 9.31
Market Cap	$404.71M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	24.6%
Days to Cover	5.33

About Verve Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardio...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Verve Therapeutics (VERV) stock?

You can purchase shares of Verve Therapeutics (NASDAQ:VERV) through any online brokerage.

View our list of the best stock brokerages

Who are Verve Therapeutics (VERV) competitors?

Other companies in Verve Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), Precigen (NASDAQ:PGEN), Celcuity (NASDAQ:CELC), Prothena Corp (NASDAQ:PRTA) and PureTech Health (NASDAQ:PRTC).

What is the forecast, or price target, for Verve Therapeutics (VERV) stock?

Verve Therapeutics has a consensus price target of $31.13.

What is the current price for Verve Therapeutics (VERV)?

The stock price for Verve Therapeutics (NASDAQ: VERV) is $4.54 last updated May 20, 2025 at 1:33 PM EDT.

Does Verve Therapeutics (VERV) pay a dividend?

There are no upcoming dividends for Verve Therapeutics.

When is Verve Therapeutics (NASDAQ:VERV) reporting earnings?

Verve Therapeutics’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Is Verve Therapeutics (VERV) going to split?

There is no upcoming split for Verve Therapeutics.

What sector and industry does Verve Therapeutics (VERV) operate in?

Verve Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.